Enhancing the incorporation of the patient’s voice in drug development and evaluation

PLAIN ENGLISH SUMMARY: People living with a condition are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation. In 2012, the U.S. Food and Drug Administration (FDA) established the Patient-Focused Drug Development (PFDD) initiative to more sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalasani, Meghana, Vaidya, Pujita, Mullin, Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879806/
https://www.ncbi.nlm.nih.gov/pubmed/29619246
http://dx.doi.org/10.1186/s40900-018-0093-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879806/
https://www.ncbi.nlm.nih.gov/pubmed/29619246
http://dx.doi.org/10.1186/s40900-018-0093-3

Ejemplares similares